PMC:7205724 / 101-279
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 151-158 | Species | denotes | patient | Tax:9606 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 31-46 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2 | 52-67 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T3 | 120-135 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-MedDRA
Id | Subject | Object | Predicate | Lexical cue | meddra_id |
---|---|---|---|---|---|
T1 | 31-46 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | immunoglobulins | http://purl.bioontology.org/ontology/MEDDRA/10021496 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 52-67 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T2 | 120-135 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 14-67 | Sentence | denotes | Anti-antibodies, immunoglobulins, and corticosteroids |
T4 | 69-79 | Sentence | denotes | Highlights |
T5 | 80-168 | Sentence | denotes | • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
3 | 151-158 | Species | denotes | patient | Tax:9606 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T15 | 6-12 | NNS | denotes | agents |
T16 | 12-13 | -COLON- | denotes | : |
T17 | 14-29 | NNS | denotes | Anti-antibodies |
T18 | 29-30 | -COMMA- | denotes | , |
T19 | 31-46 | NNS | denotes | immunoglobulins |
T20 | 46-47 | -COMMA- | denotes | , |
T21 | 48-51 | CC | denotes | and |
T22 | 52-67 | NNS | denotes | corticosteroids |
T23 | 69-79 | NNS | denotes | Highlights |
T24 | 80-81 | IN | denotes | • |
T25 | 83-87 | NNP | denotes | IVIG |
T26 | 87-88 | -COMMA- | denotes | , |
T27 | 89-97 | VBN | denotes | combined |
T28 | 98-102 | IN | denotes | with |
T29 | 103-116 | NN | denotes | moderate-dose |
T30 | 117-119 | IN | denotes | of |
T31 | 120-135 | NNS | denotes | corticosteroids |
T32 | 135-136 | -COMMA- | denotes | , |
T33 | 137-142 | MD | denotes | might |
T34 | 143-150 | VB | denotes | improve |
T35 | 151-158 | NN | denotes | patient |
T36 | 159-167 | NNS | denotes | outcomes |
T37 | 169-170 | PDT | denotes | • |
T38 | 172-175 | DT | denotes | The |
R15 | T17 | T18 | arg1Of | Anti-antibodies,"," |
R16 | T19 | T18 | arg2Of | immunoglobulins,"," |
R17 | T21 | T20 | arg1Of | and,"," |
R18 | T18 | T21 | arg1Of | ",",and |
R19 | T22 | T21 | arg2Of | corticosteroids,and |
R20 | T25 | T24 | arg1Of | IVIG,• |
R21 | T25 | T26 | arg1Of | IVIG,"," |
R22 | T25 | T27 | arg2Of | IVIG,combined |
R23 | T27 | T28 | arg1Of | combined,with |
R24 | T29 | T28 | arg2Of | moderate-dose,with |
R25 | T29 | T30 | arg1Of | moderate-dose,of |
R26 | T31 | T30 | arg2Of | corticosteroids,of |
R27 | T34 | T32 | arg1Of | improve,"," |
R28 | T25 | T33 | arg1Of | IVIG,might |
R29 | T34 | T33 | arg2Of | improve,might |
R30 | T25 | T34 | arg1Of | IVIG,improve |
R31 | T36 | T34 | arg2Of | outcomes,improve |
R32 | T36 | T35 | arg1Of | outcomes,patient |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 31-46 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 14-67 | Sentence | denotes | Anti-antibodies, immunoglobulins, and corticosteroids |
T4 | 69-79 | Sentence | denotes | Highlights |
T5 | 80-168 | Sentence | denotes | • IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes. |